Insulin-mimetics as therapeutic adjuncts for bone regeneration
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- RUTGERS THE STATE UNIV
- Publication Date
- 2014-10-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application Ser. No. 61 / 564,822, filed on Nov. 29, 2011, and No. 61 / 718,646, filed on Oct. 25, 2012, and claims priority to International Application No. PCT / US11 / 64240, filed on Dec. 9, 2011, which in turn claims priority under 35 U.S.C. §119(e) to U.S. Provisional Patent Application Ser. No. 61 / 421,921, filed on Dec. 10, 2010, No. 61 / 428,342, filed on Dec. 30, 2010, and No. 61 / 454,061, filed on Mar. 18, 2011, all of which are hereby incorporated by reference in their entireties.FIELD OF THE INVENTION
[0002] The present invention relates to use of insulin-mimetic agents as therapeutic adjuncts for bone regeneration and methods for bone healing or regeneration in patients by local administration of insulin-mimetic agents.BACKGROUND OF THE INVENTION
[0003] About six million bone fractures, including about 600,000 non-union cases, occur annually in the United St...